QA: Castle Biosciences INC in us_health_services/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001447362_2023_Castle_Biosciences_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001447362, Castle Biosciences INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 13,291,000
2 AssetsCurrent 292,288,000
3 PropertyPlantAndEquipment 14,315,000
4 remainder_Assets 127,435,000
5 LongTermLiabilities 11,623,000
6 LiabilitiesCurrent 36,556,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 32,009,000
10 GeneralAndAdministrativeExpense 143,003,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 44,903,000
16 remainder_Expenses -11,770,000
17 remainder_Revenues 137,039,000
18 remainder_NetIncome 3,968,000
19 remainder_ComprehensiveNetIncome -381,000
  yvar yval
0 Assets 447,329,000
1 Liabilities 48,179,000
2 Expenses 208,145,000
3 Revenues 137,039,000
4 StockholdersEquity 399,150,000
5 NetIncome -67,138,000
6 ComprehensiveNetIncome -67,519,000
7 BaseVar 422,520,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.06
9 EconomicCapitalRatio 2.42

Edgar->Model Mapping

Feature Distribution

Change over Time